Glessner Coleen
SEC CIK 1919170 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| EBS | Emergent BioSolutions Inc. | EVP, Quality, Ethics, CPL | 202.2K | — | $306.1K | 21 | 2022-04-08 | 2026-06-08 |
Most active insiders at EBS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | DeGolyer Donald W | Dir | — | $317.6K |
| 2 | Glessner Coleen | EVP, Quality, Ethics, CPL | — | $306.1K |
| 3 | Richard Ronald | Dir | — | $263.1K |
| 4 | Dayal Sujata Tyagi | Dir | — | $201.1K |
| 5 | Zoon Kathryn C | Dir | — | $144.5K |
| 6 | Katkin Keith | Dir | — | $128.2K |
| 7 | Williams Paul Anthony | SVP, Products Business | — | $59.0K |
| 8 | Lowry Simon C | SVP, CMO, R, D | — | — |
| 9 | Perl Jessica | SVP, GC, Corp Sec | — | — |
| 10 | Hartzel William | SVP, Bioservices | — | — |
Transactions 21
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-10 15:07 | 2026-06-08 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $8.00 | -2,018 | 202.2K | -1.0% | -$16.1K | |
| 2026-05-01 16:28 | 2026-04-29 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | A - Grant | $0.00 | +100.1K | 204.2K | +96% | $0 | |
| D | 2026-03-05 | 2026-03-05 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $8.44 | -8,199 | 104.1K | -7% | -$69.2K |
| 2026-03-03 | 2026-03-01 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $8.15 | -313 | 112.3K | -0.3% | -$2,551 | |
| 2026-02-10 | 2026-02-06 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | D - Sale to Iss | $10.92 | -28.8K | 115.5K | -20% | -$315.0K | |
| 2026-02-10 | 2026-02-06 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $10.92 | -2,852 | 112.6K | -2% | -$31.1K | |
| 2025-10-16 | 2025-10-07 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | S - Sale | $10.00 | -30.6K | 144.3K | -17% | -$306.1K | |
| 2025-06-10 | 2025-06-08 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $6.63 | -1,249 | 174.9K | -0.7% | -$8,281 | |
| 2025-04-09 | 2025-04-07 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $4.44 | -480 | 176.2K | -0.3% | -$2,131 | |
| D | 2025-03-10 | 2025-03-06 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | A - Grant | $0.00 | +62.5K | 176.7K | +55% | $0 |
| M | 2025-03-04 | 2025-02-12 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | D - Sale to Iss | $0.00 | -30.0K | 138.5K | -18% | $0 |
| 2025-03-04 | 2025-03-01 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $7.48 | -313 | 114.2K | -0.3% | -$2,341 | |
| 2024-12-10 | 2024-12-08 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $9.01 | -18.7K | 144.5K | -11% | -$168.3K | |
| 2024-06-11 | 2024-06-08 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $6.19 | -1,249 | 163.1K | -0.8% | -$7,731 | |
| 2024-04-09 | 2024-04-07 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $2.29 | -585 | 164.4K | -0.4% | -$1,340 | |
| 2024-03-04 | 2024-03-01 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $3.39 | -381 | 165.0K | -0.2% | -$1,292 | |
| DM | 2023-06-13 | 2023-06-09 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | A - Grant | $0.00 | +46.2K | 134.6K | +52% | $0 |
| 2023-04-10 | 2023-04-07 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | F - Tax | $0.00 | +480 | 120.2K | +0.4% | $0 | |
| DM | 2023-03-06 | 2023-03-02 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | A - Grant | $0.00 | +11.5K | 119.7K | +11% | $0 |
| M | 2022-12-13 | 2022-12-09 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | A - Grant | $0.00 | +96.3K | 35.9K | New | $0 |
| DM | 2022-04-12 | 2022-04-08 | EBS | Emergent BioSolutions Inc. | Glessner Coleen | EVP, Quality, Ethics, CPL | A - Grant | $0.00 | +11.8K | 11.8K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations